Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
Department of Clinical Sciences, Rheumatology, University Hospital Lund, Lund 22185, Sweden.
Anders A
AA
Bengtsson
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male
D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C511911:belimumab